CAS: 192705-80-9 - N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N′-(1,1-dimethylethyl)urea

Formel: C₂₆H₃₅Cl₂N₇O

InChl: InChI=1S/C26H35Cl2N7O/c1-6-35(7-2)14-9-8-13-29-24-30-16-17-15-18(21-19(27)11-10-12-20(21)28)23(31-22(17)32-24)33-25(36)34-26(3,4)5/h10-12,15-16H,6-9,13-14H2,1-5H3,(H3,29,30,31,32,33,34,36)

InChI Key: InChIKey=MKVMEJKNLUWFSQ-UHFFFAOYSA-N

SMILES: O=C(NC=1N=C2N=C(N=CC2=CC1C3=C(Cl)C=CC=C3Cl)NCCCCN(CC)CC)NC(C)(C)C

PD-161570

CAS: 192705-80-9

• Formel: C₂₆H₃₅Cl₂N₇O
• Molekulargewicht: 532.51

PD-161570

CAS: 192705-80-9

• Formel: C₂₆H₃₅Cl₂N₇O
• Reinheit: >98.0%(HPLC)
• Farbe und Form: White to Light yellow powder to crystal
• Molekulargewicht: 532.51

PD-161570

CAS: 192705-80-9

PD-161570 is a potent and ATP-competitive human FGF-1 receptor inhibitor with an IC50 of 39.9 …

• Formel: C₂₆H₃₅Cl₂N₇O
• Reinheit: 99.23%
• Farbe und Form: Solid
• Molekulargewicht: 532.51

PD-161570

CAS: 192705-80-9

Applications PD-161570 is a novel FGF-1 receptor tyrosine kinase inhibitor, which has been shown to …

• Formel: C₂₆H₃₅Cl₂N₇O
• Farbe und Form: Neat
• Molekulargewicht: 532.51

PD 161570

CAS: 192705-80-9

Inhibitor of FGF-1 receptor tyrosine kinase

• Formel: C₂₆H₃₅Cl₂N₇O
• Reinheit: Min. 95%
• Molekulargewicht: 532.51 g/mol